Cadila Healthcare board to consider unaudited financial results

15 Oct 2012 Evaluate
Cadila Healthcare has informed that a meeting of the board of the directors of the company will be held on November 07, 2012, to consider unaudited financial results for the quarter/half-year ended on September 30, 2012 (Q2).

The above information is a part of company's filings submitted to BSE.

Zydus Lifesciences Share Price

931.45 -3.75 (-0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×